Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details Narrative)

STOCKHOLDERS' EQUITY (Details Narrative)																						1 Months Ended		6 Months Ended		12 Months Ended
STOCKHOLDERS' EQUITY (Details Narrative)	Mar. 29, 2018 $ / shares	Jan. 02, 2018 $ / shares shares	Dec. 18, 2017 $ / shares shares	Nov. 13, 2017 USD ($) $ / shares shares	Nov. 05, 2017 $ / shares shares	Sep. 19, 2017 $ / shares shares	Aug. 24, 2017 USD ($) $ / shares shares	Aug. 22, 2017 $ / shares shares	Aug. 21, 2017 $ / shares shares	Jul. 31, 2017 $ / shares shares	Jul. 27, 2017 $ / shares shares	Jul. 26, 2017 $ / shares shares	Jul. 19, 2017 shares	Jul. 14, 2017 shares	Jul. 13, 2017 $ / shares shares	May 30, 2017 $ / shares shares	Mar. 31, 2017 USD ($) $ / shares shares	Feb. 23, 2017 USD ($) $ / shares shares	Jan. 02, 2017 shares	Dec. 06, 2016 $ / shares shares	Sep. 22, 2016	Jul. 31, 2017 USD ($) $ / shares shares	Mar. 21, 2017 USD ($) Investor $ / shares shares	Mar. 31, 2018 USD ($) $ / shares shares	Mar. 31, 2017 USD ($) $ / shares shares	Sep. 30, 2017 $ / shares shares	Sep. 30, 2016 shares	Sep. 21, 2016 shares	Apr. 05, 2016 shares	Mar. 26, 2013 shares	Dec. 10, 2012 shares	Mar. 22, 2012 shares	Aug. 03, 2006 $ / shares shares
Common stock authorized																								250,000,000		500,000,000
Common and preferred stock authorized																								265,000,000
Blank-check preferred stock authorized																								15,000,000		15,000,000
Blank-check preferred stock par value (in dollars per share) \| $ / shares																								$ 0.001		$ 0.001
Common stock issued																								4,364,311		4,299,311		200
Common stock outstanding																								4,364,311		4,299,311		200
Preferred stock, issued																								1,050,000
Preferred stock, outstanding																								1,050,000
Maturity date of the notes																								Sep. 30, 2021
Number of options outstanding																								554,059		554,083
Number of options exercised
Common stock exercise price (in dollars per share) \| $ / shares																								$ 15.75		$ 16.14
Number of stock options granted																								75,000
Total unrecognized stock-based compensation \| $																	$ 904,500							$ 822,000	$ 904,500
Number of vested shares																								389,511		350,812
Number of unvested shares																								164,548		203,271	65,596
Gross cash proceeds \| $																									2,981,300
Restricted Stock [Member]
Number of options outstanding																								280,250		222,750
Number of equity instruments other than options outstanding																								280,250		222,750
Common stock exercise price (in dollars per share) \| $ / shares																								$ 5.02		$ 5.31
Number of stock options granted																								57,500
Total unrecognized stock-based compensation \| $																	438,300							$ 139,100	438,300
Number of vested shares																								237,834		167,708
Number of unvested shares																								42,416		55,042
Number of shares granted under the plan																								57,500
Stock Option [Member]
Total unrecognized stock-based compensation \| $																	$ 466,200							$ 682,900	$ 466,200
2006 Stock Incentive Plan [Member]
Common stock outstanding																								1,513
Number of shares reserved for future issuance																																	3,339
Number of options exercised																								0
2012 Omnibus Incentive Compensation Plan [Member]
Common stock purchase price (in dollars per share) \| $ / shares									$ 0.001
Common stock authorized									975,000
Weighted exercise price of awarded shares (in dollars per share) \| $ / shares																								$ 6.77
Number of options outstanding																								552,546
Common stock exercise price (in dollars per share) \| $ / shares																$ 6.00
Number of options authorized																													200,000	75,000	27,500	1,667
Number of authorized shares available for grant previously									885,781
Number of authorized shares available for grant									1,570,248
Maximum number of shares granted to individual									150,000
Number of stock options granted																10,000			50,000
Description of plan terms																					of each year through 2022, automatically increases the number of shares subject to the 2012 Plan by the lesser of: (a) a number equal to 10% of the shares of Common Stock authorized under the 2012 Plan as of the preceding December 31st, or (b) an amount, or no amount, as determined by the Board, but in no event may the number of shares of Common Stock authorized under the 2012 Plan exceed 885,781 and (iii) increase the annual individual award limits under the 2012 Plan to 100,000 shares of Common Stock, subject to adjustment in accordance with the 2012 Plan. Per the above mentioned “evergreen” provision, an additional 50,000 shares were automatically allocated for distribution under the 2012 Plan as of January 1, 2017.
Number of vested shares																										2,000
2012 Omnibus Incentive Compensation Plan [Member] \| Restricted Stock [Member]
Number of shares reserved for future issuance																								239,704
Number of equity instruments other than options outstanding																								280,250
Public Offering [Member]
Stock price (in dollars per share) \| $ / shares										$ 5.25												$ 5.25
Proceeds from public offering \| $																						$ 8,793,750
Public Offering [Member] \| Common Stock and Warrants [Member]
Proceeds from public offering \| $																						$ 8,790,000
45-day Option Over-Allotment Option [Member]
Number of common stock issued																						251,250
Warrant [Member] \| Private Placement [Member]
Common stock purchase price (in dollars per share) \| $ / shares	$ 2.34
Warrant term	5 years
Warrant [Member] \| Pro-Rate Option [Member]
Number of common stock issued															2,539,061
Warrant exercise price (in dollars per share) \| $ / shares															$ 5.25
Number of each warrant called															1
Fair value, maturity															5 years
Warrant [Member] \| Public Offering [Member]
Number of common stock issued													134,000									1,675,000
Warrant exercise price (in dollars per share) \| $ / shares										$ 5.25												$ 5.25
Number of each warrant called										1												1
Stock price (in dollars per share) \| $ / shares										$ 6.55												$ 6.55
Warrant term																						5 years
Common Stock [Member] \| Public Offering [Member]
Number of common stock issued																						1,675,000
Maximum [Member] \| 2006 Stock Incentive Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares																																	$ 5,760
Maximum [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares																								$ 600
Minimum [Member] \| 2006 Stock Incentive Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares																																	$ 2,400
Minimum [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares																								$ 3.60
Four Accredited Investors [Member] \| Private Placement [Member]
Number of common stock issued																							237,000
Proceeds from issuance of private placement \| $																							$ 1,481,300
Shares issued (in dollars per share) \| $ / shares																							$ 6.25
Number of accredited investors \| Investor																							4
RSJ Private Equity (Michal Votruba) [Member] \| Private Placement [Member]
Number of common stock issued																							160,000
Proceeds from issuance of private placement \| $																							$ 1,000,000
John Pappajohn [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares						$ 3.60
Number of stock options granted						12,000
Number of restricted common stock						12,000
John Pappajohn [Member] \| Private Placement [Member]
Number of common stock issued																							72,000
Proceeds from issuance of private placement \| $																							$ 450,000
Geoffrey E. Harris [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares						$ 3.60
Number of stock options granted						18,000
Number of restricted common stock						18,000
Geoffrey E. Harris [Member] \| Private Placement [Member]
Number of common stock issued																							5,000
Proceeds from issuance of private placement \| $																							$ 31,300
Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares								$ 4.10		$ 3.81	$ 7.25	$ 4.15										$ 3.81
Number of stock options granted								5,000		10,000	5,000	5,000
Dr. Donald D'Ambrosio [Member]
Number of options outstanding																	18,000								18,000
Common stock exercise price (in dollars per share) \| $ / shares																	$ 5.90								$ 5.90
Description of vesting rights																	(i) the option to purchase 15,000 shares vesting in equal monthly installments over 36 months from March 31, 2017, and (ii) the option to purchase 3,000 shares vesting upon the Company's successful listing of its common stock on a national securities exchange.
Underwriters [Member] \| Warrant [Member] \| 45-day Option Over-Allotment Option [Member]
Number of common stock issued							213,800
Proceeds from issuance of warrants \| $							$ 2,100
Stock price (in dollars per share) \| $ / shares							$ 0.01
Mr. Robin L. Smith, M.D [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares									$ 4.16
Number of stock options granted									50,000
Number of restricted common stock				7,500
David Nash [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares					$ 3.88
Number of stock options granted					20,000
Mr. Plotkin [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares				$ 3.96
Number of stock options granted				35,000
Amount of vested shares \| $				$ 2,500,000
Mr. Plotkin [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche One [Member]
Number of vested shares				11,667
Mr. Plotkin [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche Two [Member]
Number of vested shares				11,667
Mr. Plotkin [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche Three [Member]
Number of vested shares				11,666
Three Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares			$ 3.74
Number of stock options granted			5,000
Mr. George C. Carpenter IV [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of restricted common stock				7,500
Mr. Donald DAmbrosio [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of restricted common stock				7,500
Various Employees [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of restricted common stock				15,000
One Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares		$ 3.37
Number of stock options granted		5,000
Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member]
Number of common shares purchased																				10,000,000
Agreement term																				30 months
Common stock purchase price (in dollars per share) \| $ / shares																		$ 7.25		$ 0.50
Description of purchase notice																				Amount equal to 50,000 shares and the closing sale price of the Company's stock is greater than $0.50 per share, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate shares of the Company’s common stock traded on its principal market on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares the Company may determine. The purchase price per share pursuant to such VWAP Purchase Notice is generally 95% of the volume-weighted average price for the Company’s common stock traded on its principal market on the VWAP Purchase Date.
Number of common stock issued																		20,000
Proceeds from issuance of private placement \| $																		$ 145,000
Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member] \| Commitment Shares [Member]
Number of common shares purchased																				80,000
Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member] \| Maximum [Member]
Number of shares sold per day																				50,000
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| Stock Option [Member]
Expiration period														10 years
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Restricted Stock [Member]
Number of shares granted under the plan														25,000
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Stock Option [Member]
Number of stock options granted														75,000
Number of option to purchase granted annual award limits														50,000
Management and administrative services agreement [Member] \| Arcadian Telepshyciatry Services LLC, PA [Member]
Initial agreement term (in years)				20 years
Management and administrative services agreement [Member] \| Arcadian Telepshyciatry Services LLC, PC [Member]
Initial agreement term (in years)				20 years